Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Upper limb arterial thromboembolism: a systematic review on incidence, risk factors, and prognosis, including a meta-analysis of risk-modifying drugs.

Andersen LV, Lip GY, Lindholt JS, Frost L.

J Thromb Haemost. 2013 May;11(5):836-44. doi: 10.1111/jth.12181. Review.

PMID:
23433284
[PubMed - indexed for MEDLINE]
2.

Atrial fibrillation and upper limb thromboembolectomy: a national cohort study.

Andersen LV, Mortensen LS, Lip GY, Lindholt JS, Faergeman O, Henneberg EW, Frost L.

J Thromb Haemost. 2011 Sep;9(9):1738-43. doi: 10.1111/j.1538-7836.2011.04435.x.

PMID:
21736696
[PubMed - indexed for MEDLINE]
3.

Stroke Prevention in Atrial Fibrillation [Internet].

Lopes RD, Crowley MJ, Shah BR, Melloni C, Wood KA, Chatterjee R, Povsic TJ, Dupre ME, Kong DF, de Barros e Silva PGM, dos Santos MHH, Armaganijan LV, Katz M, Kosinski A, McBroom AJ, Chobot MM, Gray R, Sanders GD.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Aug.

PMID:
24049843
[PubMed]
Books & Documents
4.

Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.

Aguilar MI, Hart R.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001927. Review.

PMID:
16034869
[PubMed - indexed for MEDLINE]
5.

WITHDRAWN: Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001938. Review.

PMID:
17636690
[PubMed - indexed for MEDLINE]
6.

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB.

Cochrane Database Syst Rev. 2001;(1):CD001938. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001938.

PMID:
11279741
[PubMed - indexed for MEDLINE]
7.

Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.

Segal JB, McNamara RL, Miller MR, Kim N, Goodman SN, Powe NR, Robinson KA, Bass EB.

J Gen Intern Med. 2000 Jan;15(1):56-67.

PMID:
10632835
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE.

JAMA. 2003 Nov 26;290(20):2685-92.

PMID:
14645310
[PubMed - indexed for MEDLINE]
9.

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).

Patel MR, Hellkamp AS, Lokhnygina Y, Piccini JP, Zhang Z, Mohanty S, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW.

J Am Coll Cardiol. 2013 Feb 12;61(6):651-8. doi: 10.1016/j.jacc.2012.09.057.

PMID:
23391196
[PubMed - indexed for MEDLINE]
Free Article
10.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
[PubMed - indexed for MEDLINE]
11.

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.

Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS.

Circulation. 2005 Sep 20;112(12):1687-91. Epub 2005 Sep 12.

PMID:
16157766
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.

Ruiz-Nodar JM, Marín F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Valdés M, Lip GY.

J Am Coll Cardiol. 2008 Feb 26;51(8):818-25. doi: 10.1016/j.jacc.2007.11.035.

PMID:
18294566
[PubMed - indexed for MEDLINE]
Free Article
13.

Antiplatelet agents and anticoagulants for hypertension.

Lip GY, Felmeden DC, Dwivedi G.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003186. doi: 10.1002/14651858.CD003186.pub3. Review.

PMID:
22161375
[PubMed - indexed for MEDLINE]
14.

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.

Friberg L, Rosenqvist M, Lip GY.

Eur Heart J. 2012 Jun;33(12):1500-10. doi: 10.1093/eurheartj/ehr488. Epub 2012 Jan 13.

PMID:
22246443
[PubMed - indexed for MEDLINE]
Free Article
15.

Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.

Piccini JP, Stevens SR, Lokhnygina Y, Patel MR, Halperin JL, Singer DE, Hankey GJ, Hacke W, Becker RC, Nessel CC, Mahaffey KW, Fox KA, Califf RM, Breithardt G; ROCKET AF Steering Committee & Investigators.

J Am Coll Cardiol. 2013 May 14;61(19):1998-2006. doi: 10.1016/j.jacc.2013.02.025. Epub 2013 Mar 14.

PMID:
23500298
[PubMed - indexed for MEDLINE]
Free Article
16.

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ.

Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24. Review.

PMID:
22537354
[PubMed - indexed for MEDLINE]
17.

[Atrial fibrillation and stroke].

Mattle HP, Schwerzmann M, Seiler Ch.

Ther Umsch. 2003 Sep;60(9):527-34. Review. German.

PMID:
14579621
[PubMed - indexed for MEDLINE]
18.

Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis.

Albertsen IE, Rasmussen LH, Overvad TF, Graungaard T, Larsen TB, Lip GY.

Stroke. 2013 May;44(5):1329-36. doi: 10.1161/STROKEAHA.113.000883. Epub 2013 Mar 12. Review.

PMID:
23482597
[PubMed - indexed for MEDLINE]
Free Article
19.

Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.

Dogliotti A, Paolasso E, Giugliano RP.

Clin Cardiol. 2013 Feb;36(2):61-7. doi: 10.1002/clc.22081. Epub 2013 Jan 21. Review.

PMID:
23338902
[PubMed - indexed for MEDLINE]
20.

Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.

Agarwal S, Hachamovitch R, Menon V.

Arch Intern Med. 2012 Apr 23;172(8):623-31; discussion 631-3. doi: 10.1001/archinternmed.2012.121. Epub 2012 Mar 26. Review.

PMID:
22450212
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk